Anaplastic Astrocytoma
Showing NaN - NaN of 26
Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)
Recruiting
- Glioblastoma
- +3 more
- Adaptive Radiotherapy
-
New York, New YorkColumbia University Irving Medical Center
Oct 27, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)
Recruiting
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
New York, New YorkLenox Hill Brain Tumor Center
Nov 10, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients
Recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
-
Buffalo, New York
- +2 more
Jul 8, 2022
Anaplastic Astrocytoma, Anaplastic Ependymoma, Anaplastic Oligodendroglioma Trial in United States (other, drug, procedure)
Active, not recruiting
- Anaplastic Astrocytoma
- +6 more
- Laboratory Biomarker Analysis
- +4 more
-
Los Angeles, California
- +11 more
Jul 1, 2022
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)
Active, not recruiting
- Anaplastic Astrocytoma
- Recurrent Anaplastic Astrocytoma
-
Birmingham, Alabama
- +78 more
Jan 19, 2022
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)
Suspended
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Bevacizumab and Carboplatin
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 27, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of
Completed
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Super-Selective Intraarterial Intracranial Infusion of Temozolomide
-
New York, New YorkLenox Hill Brain Tumor Center
Mar 2, 2021
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Worldwide (Toca 511, Toca FC, Lomustine)
Terminated
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Toca 511
- +4 more
-
Phoenix, Arizona
- +66 more
Feb 6, 2020
Genetic Analysis of Brain Tumors
Terminated
- Glioma
- +4 more
-
Bethesda, Maryland
- +2 more
Dec 6, 2019
Anaplastic Astrocytoma, Brain Stem Glioma, Childhood Mixed Glioma Trial in United States (radiation, other, drug)
Completed
- Anaplastic Astrocytoma
- +12 more
- 3-Dimensional Conformal Radiation Therapy
- +5 more
-
Los Angeles, California
- +11 more
Jul 17, 2019
Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy
Withdrawn
- Glioblastoma Multiforme
- +2 more
- MRS Spectroscopy
-
New York, New YorkWeill Cornell Medical College Department of Neurosurgery
May 30, 2019
Anaplastic Astrocytoma, Anaplastic Ependymoma, Astrocytoma, Grade II Trial in United States (imetelstat sodium)
Terminated
- Anaplastic Astrocytoma
- +8 more
- imetelstat sodium
-
Los Angeles, California
- +10 more
Jun 20, 2018
Teratoid Tumor, Atypical, Choroid Plexus Tumors, Anaplastic Astrocytoma Trial in United States (azurin-derived cell-penetrating
Completed
- Teratoid Tumor, Atypical
- +9 more
- azurin-derived cell-penetrating peptide p28
-
Los Angeles, California
- +10 more
Aug 3, 2017
Glioblastoma, Malignant Glioma, Brain Tumors Trial in New York (Stem Cell Radiotherapy (ScRT) and Temozolomide)
Terminated
- Glioblastoma
- +3 more
- Stem Cell Radiotherapy (ScRT) and Temozolomide
-
New York, New YorkRoosevelt Hospital
Apr 28, 2017
Glioblastoma Multiforme (GBM), ANAPLASTIC ASTROCYTOMA (AOA), GBM Trial in New York (Superselective Intraarterial Cerebral
Completed
- Glioblastoma Multiforme (GBM)
- +3 more
- Superselective Intraarterial Cerebral Infusion of Cetuximab
-
New York, New YorkLenox Hill Brain Tumor Center
Jan 30, 2017
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Erlotinib)
Completed
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
-
New York, New YorkLenox Hill Brain Tumor Center
Jan 12, 2016
Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Super-Selective Intraarterial Intracranial Infusion of
Completed
- Glioblastoma Multiforme
- Anaplastic Astrocytoma
- Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB
-
New York, New YorkLenox Hill Brain Tumor Center
Apr 20, 2015
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (IL13-PE38QQR, targeted fusion protein
Completed
- Malignant Glioma
- +4 more
- IL13-PE38QQR
- +2 more
-
San Francisco, California
- +3 more
Jun 2, 2011